NCT05966688View on ClinicalTrials.gov

A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 4, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

SPR720

Multiple oral doses of SPR720 capsules.

DRUG

Azithromycin

Multiple oral doses of azithromycin.

DRUG

Ethambutol

Multiple oral doses of ethambutol.

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors

Lead Sponsor

Spero Therapeutics
All Listed Sponsors
lead

Spero Therapeutics

INDUSTRY